Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie’s Imbruvica Expected to Become a Leading Oncology Drug
AbbVie’s Imbruvica Expected to Become a Leading Oncology Drug
AbbVie’s Imbruvica Expected to Become a Leading Oncology Drug
Submitted by
admin
on November 29, 2016 - 9:46am
Source:
Market Realist
News Tags:
AbbVie
Imbruvica
oncology
CLL
Headline:
AbbVie’s Imbruvica Expected to Become a Leading Oncology Drug
Do Not Allow Advertisers to Use My Personal information
